Related Experiment Videos
Chromatography of plasmid DNA
M M Diogo1, J A Queiroz, D M F Prazeres
1Centro de Engenharia Biológica e Química, Instituto Superior Técnico, Av. Rovisco Pais, 1049-001 Lisboa, Portugal.
Journal of Chromatography. A
|April 23, 2005
Summary
Liquid chromatography is crucial for manufacturing therapeutic plasmid DNA (pDNA) for gene therapies and vaccines. This review covers pDNA chromatography techniques, their limitations, and strategies for improving purification and quality control.
Area of Science:
- Biotechnology
- Analytical Chemistry
- Process Chemistry
Background:
- Therapeutic plasmid DNA (pDNA) manufacturing relies heavily on chromatography for purification.
- Chromatography serves both preparative and analytical roles in pDNA production.
- Ensuring pDNA quality is critical for gene therapy and DNA vaccination applications.
Purpose of the Study:
- To provide a comprehensive overview of plasmid DNA chromatography in therapeutic manufacturing.
- To discuss the specificity and limitations inherent in pDNA purification via chromatography.
- To present current and potential strategies for overcoming these chromatographic limitations.
Main Methods:
- Review of existing literature on pDNA chromatography applications.
- Analysis of different chromatography types used for therapeutic pDNA purification.
- Evaluation of advantages and disadvantages of various chromatographic techniques.
Main Results:
- Chromatography is indispensable for large-scale pDNA production and quality assessment.
- Specific challenges exist in achieving high purity and yield due to pDNA characteristics.
- Various strategies, including novel approaches, are being explored to enhance chromatographic performance.
Conclusions:
- Liquid chromatography is a cornerstone technology in therapeutic pDNA manufacturing.
- Understanding and addressing chromatographic limitations are key to efficient pDNA production.
- Continued innovation in chromatography will support advancements in gene therapy and DNA vaccination.